GlassScriptPhysician profile
Ashley Ann Albert
NPI 1346668514
$6,809.86
in general payments reported to CMS, 2019-2025
18 companies · $1,721 in 2025
The $1,721 reported for 2025 was more than what 89% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $298 · 2021: $19.01 · 2022: $481 · 2023: $1,469 · 2024: $2,823 · 2025: $1,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,179 · Food and Beverage: $1,800 · Entertainment: $33.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,179.36 |
| Food and Beverage | $1,799.63 |
| Entertainment | $33.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $5,208.04 | 2023-2025 | Gammatile, Gammatile |
| Elekta, INC. | $244.97 | 2020 | |
| Intuitive Surgical, INC. | $226.99 | 2022-2025 | |
| Icotec Medical INC. | $213.67 | 2022 | |
| Tactile Systems Technology INC | $199.05 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Progenics Pharmaceuticals, INC. | $129.82 | 2023-2025 | Pylarify |
| Abbvie INC. | $101.80 | 2023-2025 | Lupron Depot |
| Pfizer INC. | $84.23 | 2023-2025 | |
| Daiichi Sankyo INC. | $82.66 | 2020-2023 | Enhertu |
| Astrazeneca Pharmaceuticals LP | $77.40 | 2022-2025 | Imfinzi |
| Ge Healthcare | $64.62 | 2025 | |
| Boston Scientific Corporation | $56.73 | 2023-2025 | Spaceoar Vue System - 10ml |
| Argentum Medical | $33.51 | 2024 | |
| Teleflex LLC | $22.11 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $19.01 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $16.18 | 2025 | Erleada, Balversa |
| Incyte Corporation | $15.59 | 2020 | |
| Puma Biotechnology, INC. | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Albert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.